Source:http://linkedlifedata.com/resource/pubmed/id/15307183
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-8-12
|
pubmed:abstractText |
The BZLF1 antigen of Epstein-Barr virus includes three overlapping sequences of different lengths that conform to the binding motif of human leukocyte antigen (HLA) B*3501. These 9-mer (56LPQGQLTAY64), 11-mer (54EPLPQGQLTAY64), and 13-mer (52LPEPLPQGQLTAY64) peptides all bound well to B*3501; however, the CTL response in individuals expressing this HLA allele was directed strongly and exclusively towards the 11-mer peptide. In contrast, EBV-exposed donors expressing HLA B*3503 showed no significant CTL response to these peptides because the single amino acid difference between B*3501 and B*3503 within the F pocket inhibited HLA binding by these peptides. The extraordinarily long 13-mer peptide was the target for the CTL response in individuals expressing B*3508, which differs from B*3501 at a single position within the D pocket (B*3501, 156Leucine; B*3508, 156Arginine). This minor difference was shown to enhance binding of the 13-mer peptide, presumably through a stabilizing interaction between the negatively charged glutamate at position 3 of the peptide and the positively charged arginine at HLA position 156. The 13-mer epitope defined in this study represents the longest class I-binding viral epitope identified to date as a minimal determinant. Furthermore, the potency of the response indicates that peptides of this length do not present a major structural barrier to CTL recognition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BZLF1 protein, Herpesvirus 4, Human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B35 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Immunodominant Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2004 Wiley-VCH Verlag GmbH & Co.
|
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2510-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15307183-Antigen Presentation,
pubmed-meshheading:15307183-Cell Line,
pubmed-meshheading:15307183-DNA-Binding Proteins,
pubmed-meshheading:15307183-Epitopes, T-Lymphocyte,
pubmed-meshheading:15307183-HLA-B35 Antigen,
pubmed-meshheading:15307183-Herpesvirus 4, Human,
pubmed-meshheading:15307183-Humans,
pubmed-meshheading:15307183-Immunodominant Epitopes,
pubmed-meshheading:15307183-Peptide Fragments,
pubmed-meshheading:15307183-Polymorphism, Genetic,
pubmed-meshheading:15307183-T-Lymphocytes,
pubmed-meshheading:15307183-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:15307183-Trans-Activators,
pubmed-meshheading:15307183-Viral Proteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length.
|
pubmed:affiliation |
Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.
|
pubmed:publicationType |
Journal Article
|